To assess the effect of the classical complement pathway on TTV, 64 healthy volunteers and 10 kidney transplant recipients treated with the anti‐C1s antibody sutimlimab were analyzed for serum TTV copy numbers (c/mL) by qPCR. This evidence concerns the gene EXT1 and urogenital neoplasm.